LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 117

Search options

  1. Article: Nanotechnology-Based Strategies to Combat Multidrug-Resistant

    Hetta, Helal F / Ramadan, Yasmin N / Al-Kadmy, Israa M S / Ellah, Noura H Abd / Shbibe, Lama / Battah, Basem

    Pathogens (Basel, Switzerland)

    2023  Volume 12, Issue 8

    Abstract: An emerging multidrug-resistant pathogenic yeast ... ...

    Abstract An emerging multidrug-resistant pathogenic yeast called
    Language English
    Publishing date 2023-08-13
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens12081033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Antibacterial and wound-healing potential of PLGA/spidroin nanoparticles: a study on earthworms as a human skin model.

    Abd El-Aziz, Fatma El-Zahraa A / Hetta, Helal F / Abdelhamid, Basma N / Abd Ellah, Noura H

    Nanomedicine (London, England)

    2022  Volume 17, Issue 6, Page(s) 353–365

    Abstract: Aim: ...

    Abstract Aim:
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Fibroins ; Humans ; Nanoparticles ; Oligochaeta ; Polylactic Acid-Polyglycolic Acid Copolymer
    Chemical Substances Anti-Bacterial Agents ; Polylactic Acid-Polyglycolic Acid Copolymer (1SIA8062RS) ; Fibroins (9007-76-5)
    Language English
    Publishing date 2022-02-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 2277839-1
    ISSN 1748-6963 ; 1743-5889
    ISSN (online) 1748-6963
    ISSN 1743-5889
    DOI 10.2217/nnm-2021-0325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Preoperative Duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: A dose-ranging randomized controlled trial.

    Hetta, Diab Fuad / Elgalaly, Nourhan Alaa / Hetta, Helal F / Fattah Mohammad, Montaser A

    Journal of clinical anesthesia

    2020  Volume 67, Page(s) 110007

    Abstract: ... Intervention: Participants were randomly allocated into 4 equal groups received 2 h preoperatively, placebo ... N = 22) tablet.: Measurements: The primary outcome; 24 h cumulative postoperative morphine ... consumption of morphine (mg) in the first postoperative 24 h was significantly decreased in both (D60 and D90 ...

    Abstract Objective: Duloxetine has been recently used as a part of multimodal analgesia in perioperative settings, yet the optimal dose of Duloxetine is not determined.
    Design: A parallel, randomized, placebo-controlled trial.
    Setting: Tertiary level oncology center.
    Patients: 88 female patients with breast cancer were subjected to modified radical mastectomy (MRM) with ASA class I and II were recruited.
    Intervention: Participants were randomly allocated into 4 equal groups received 2 h preoperatively, placebo (D0, N = 22), Duloxetine 30 mg (D30, N = 22), Duloxetine 60 mg (D60, N = 22) and Duloxetine 90 mg (D90, N = 22) tablet.
    Measurements: The primary outcome; 24 h cumulative postoperative morphine consumption and the secondary outcomes; VAS score of pain intensity, quality of recovery (QoR-40), time to Aldrete 9, and side effects (sedation and vomiting) were measured.
    Results: The median (IQR) consumption of morphine (mg) in the first postoperative 24 h was significantly decreased in both (D60 and D90) groups compared to (D0 and D30) groups, P < 0.001(Bonferroni corrected), however, a non-significant reduction was observed between D90 group vs. D60 group and D30 group vs. D0 group, P = 0.595 and P = 0.462 respectively, D60 vs. D0; 0(0-6) vs. 10(9-12), D60 vs. D30; 0(0-6) vs. 9(8-11), D90 vs. D0; 0(0-5) vs. 10(9-12), D90 vs. D30; 0(0-5) vs. 9(8-11), D90 vs. D60; 0(0-5) vs. 0(0-6), D30 vs. D0; 9(8-11) vs. 10(9-12), patients in D90 group took longer time to recover from anesthesia " time to Aldrete 9" and showed an increased level of sedation in comparison with other groups, vomiting was more frequent in the D90 group.
    Conclusion: Preoperative oral Duloxetine of 60 mg, for patients subjected to MRM is the optimal dose considering its analgesic efficacy and side effects.
    Trial registration: The trial was registered at Clinical Trials.gov with unique ID number; NCT03468348.
    MeSH term(s) Acute Pain ; Analgesics, Opioid/adverse effects ; Breast Neoplasms/surgery ; Double-Blind Method ; Duloxetine Hydrochloride/adverse effects ; Female ; Humans ; Mastectomy/adverse effects ; Mastectomy, Modified Radical ; Pain Measurement ; Pain, Postoperative/drug therapy ; Pain, Postoperative/prevention & control
    Chemical Substances Analgesics, Opioid ; Duloxetine Hydrochloride (9044SC542W)
    Language English
    Publishing date 2020-08-22
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1011618-7
    ISSN 1873-4529 ; 0952-8180
    ISSN (online) 1873-4529
    ISSN 0952-8180
    DOI 10.1016/j.jclinane.2020.110007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Quality Control, Anti-Hyperglycemic, and Anti-Inflammatory Assessment of

    Abd El Hafeez, Mohamed S / El Gindi, Omayma / Hetta, Mona H / Aly, Hanan F / Ahmed, Safwat A

    Plants (Basel, Switzerland)

    2022  Volume 11, Issue 6

    Abstract: Colvillea ... ...

    Abstract Colvillea racemosa
    Language English
    Publishing date 2022-03-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2704341-1
    ISSN 2223-7747
    ISSN 2223-7747
    DOI 10.3390/plants11060830
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.

    Abdellatif, Ahmed A H / Tawfeek, Hesham M / Abdelfattah, Ahmed / El-Saber Batiha, Gaber / Hetta, Helal F

    Journal of drug delivery science and technology

    2021  Volume 63, Page(s) 102435

    Abstract: The current world health threat posed by the novel coronavirus disease of 2019 (COVID-19) calls for the urgent development of effective therapeutic options. COVID-19 needs daunting routes such as nano-antivirals. Hence, the role of nanotechnology is very ...

    Abstract The current world health threat posed by the novel coronavirus disease of 2019 (COVID-19) calls for the urgent development of effective therapeutic options. COVID-19 needs daunting routes such as nano-antivirals. Hence, the role of nanotechnology is very critical in combating this nano-enemy "virus." Although substantial resources are under ongoing attention for prevention and care, we would like to start sharing with readers our vision of the role of inhaled nanomaterials and targeting systems that can play an important role in the fight against the COVID-19. In this review, we underline the genomic structure of COVID-19, recent modes of virus transmission with measures to control the infection, pathogenesis, clinical presentation of SARS-CoV-2, and how much the virus affects the lung. Additionally, the recent therapeutic approaches for managing COVID-19 with emphasis on the value of nanomaterial-based technical approaches are discussed in this review. This review also focuses on the safe and efficient delivery of useable targeted therapies using designed nanocarriers. Moreover, the effectiveness and availability of active targeting of certain specific receptors expressed on the coronavirus surfaces via tailored ligand nanoparticles are manipulated. It was also highlighted in this review the role of inhaled medicines including antivirals and repurposed drugs for fighting the associated lung disorders and efficiency of developed vaccines. Moreover, the inhalation delivery safety techniques were also highlighted.
    Language English
    Publishing date 2021-02-19
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 2141013-6
    ISSN 1773-2247
    ISSN 1773-2247
    DOI 10.1016/j.jddst.2021.102435
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Meat and meat products as potential sources of emerging MDR Bacillus cereus: groEL gene sequencing, toxigenic and antimicrobial resistance.

    Algammal, Abdelazeem M / Eid, Hamza M / Alghamdi, Saad / Ghabban, Hanaa / Alatawy, Roba / Almanzalawi, Enas A / Alqahtani, Tahani M / Elfouly, Sabreen G / Mohammed, Gihan M / Hetta, Helal F / El-Tarabili, Reham M

    BMC microbiology

    2024  Volume 24, Issue 1, Page(s) 50

    Abstract: Background: Bacillus cereus is implicated in severe foodborne infection in humans. This study intended to assess the occurrence, groEL gene sequencing, biofilm production, and resistance profiles of emerged multidrug resistant (MDR) B. cereus in meat ... ...

    Abstract Background: Bacillus cereus is implicated in severe foodborne infection in humans. This study intended to assess the occurrence, groEL gene sequencing, biofilm production, and resistance profiles of emerged multidrug resistant (MDR) B. cereus in meat and meat product samples. Moreover, this work highlights the virulence and toxigenic genes (hblABCD complex, nheABC complex, cytK, ces, and pc-plc) and antimicrobial resistance genes (bla1, tetA, bla2, tetB, and ermA).
    Methods: Consequently, 200 samples (sausage, minced meat, luncheon, beef meat, and liver; n = 40 for each) were indiscriminately collected from commercial supermarkets in Port Said Province, Egypt, from March to May 2021. Subsequently, food samples were bacteriologically examined. The obtained isolates were tested for groEL gene sequence analysis, antibiotic susceptibility, biofilm production, and PCR screening of toxigenic and resistance genes.
    Results: The overall prevalence of B. cereus among the inspected food samples was 21%, where the highest predominance was detected in minced meat (42.5%), followed by beef meat (30%). The phylogenetic analysis of the groEL gene exposed that the examined B. cereus strain disclosed a notable genetic identity with other strains from the USA and China. Moreover, the obtained B. cereus strains revealed β-hemolytic activity, and 88.1% of the recovered strains tested positive for biofilm production. PCR evidenced that the obtained B. cereus strains usually inherited the nhe complex genes (nheA and nheC: 100%, and nheB: 83.3%), followed by cytK (76.2%), hbl complex (hblC and hblD: 59.5%, hblB: 16.6%, and hblA: 11.9%), ces (54.7%), and pc-plc (30.9%) virulence genes. Likewise, 42.9% of the examined B. cereus strains were MDR to six antimicrobial classes and encoded bla1, bla2, ermA, and tetA genes.
    Conclusion: In summary, this study highlights the presence of MDR B. cereus in meat and meat products, posing a significant public health risk. The contamination by B. cereus is common in minced meat and beef meat. The molecular assay is a reliable fundamental tool for screening emerging MDR B. cereus strains in meat and meat products.
    MeSH term(s) Humans ; Animals ; Cattle ; Food Microbiology ; Enterotoxins/genetics ; Meat Products ; Bacillus cereus ; Anti-Bacterial Agents/pharmacology ; Phylogeny ; Drug Resistance, Bacterial/genetics ; Meat
    Chemical Substances Enterotoxins ; Anti-Bacterial Agents
    Language English
    Publishing date 2024-02-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 2041505-9
    ISSN 1471-2180 ; 1471-2180
    ISSN (online) 1471-2180
    ISSN 1471-2180
    DOI 10.1186/s12866-024-03204-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Nutritional, Antioxidant, Antimicrobial, and Anticholinesterase Properties of

    Orabi, Mohamed A A / Hasan, Aso Hameed / AbouZid, Sameh F / El Amir, Dalia / Hetta, Mona H / Awadh, Ahmed Abdullah Al / Alqahtani, Omaish Salman / Hatano, Tsutomu / El-Shanawany, Mohamed A

    Metabolites

    2023  Volume 13, Issue 9

    Abstract: Dietary fruits and vegetables play a vital role as food and drugs and are the main sources of antioxidant defences against degenerative diseases, such as brain dysfunctions, cardiovascular diseases, immune system deteriorations, and cancers, brought on ... ...

    Abstract Dietary fruits and vegetables play a vital role as food and drugs and are the main sources of antioxidant defences against degenerative diseases, such as brain dysfunctions, cardiovascular diseases, immune system deteriorations, and cancers, brought on by oxidative damage.
    Language English
    Publishing date 2023-09-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662251-8
    ISSN 2218-1989
    ISSN 2218-1989
    DOI 10.3390/metabo13091013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.

    Abd Ellah, Noura H / Gad, Sheryhan F / Muhammad, Khalid / E Batiha, Gaber / Hetta, Helal F

    Nanomedicine (London, England)

    2020  Volume 15, Issue 21, Page(s) 2085–2102

    Abstract: The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific ... ...

    Abstract The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific treatment against SARS-CoV-2, effective vaccines and antiviral agents are urgently needed to properly restrain the COVID-19 pandemic. Repositioned drugs such as remdesivir have revealed a promising clinical efficacy against COVID-19. Interestingly, nanomedicine as a promising therapeutic approach could effectively help win the battle between coronaviruses (CoVs) and host cells. This review discusses the potential therapeutic approaches, in addition to the contribution of nanomedicine against CoVs in the fields of vaccination, diagnosis and therapy.
    MeSH term(s) Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Antiviral Agents/therapeutic use ; Betacoronavirus/drug effects ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; COVID-19 Testing ; COVID-19 Vaccines ; Clinical Laboratory Techniques ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/therapy ; Drug Repositioning ; Host Microbial Interactions/drug effects ; Humans ; Nanomedicine/methods ; Nanotechnology/methods ; Pandemics/prevention & control ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Vaccines, Synthetic/pharmacology ; Viral Vaccines/pharmacology ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; COVID-19 Vaccines ; Vaccines, Synthetic ; Viral Vaccines ; remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Alanine (OF5P57N2ZX)
    Keywords covid19
    Language English
    Publishing date 2020-07-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2277839-1
    ISSN 1748-6963 ; 1743-5889
    ISSN (online) 1748-6963
    ISSN 1743-5889
    DOI 10.2217/nnm-2020-0247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives.

    Hetta, Helal F / Ramadan, Yasmin N / Al-Harbi, Alhanouf I / A Ahmed, Esraa / Battah, Basem / Abd Ellah, Noura H / Zanetti, Stefania / Donadu, Matthew Gavino

    Biomedicines

    2023  Volume 11, Issue 2

    Abstract: The wide spread of antibiotic resistance has been alarming in recent years and poses a serious global hazard to public health as it leads to millions of deaths all over the world. The wide spread of resistance and sharing resistance genes between ... ...

    Abstract The wide spread of antibiotic resistance has been alarming in recent years and poses a serious global hazard to public health as it leads to millions of deaths all over the world. The wide spread of resistance and sharing resistance genes between different types of bacteria led to emergence of multidrug resistant (MDR) microorganisms. This problem is exacerbated when microorganisms create biofilms, which can boost bacterial resistance by up to 1000-fold and increase the emergence of MDR infections. The absence of novel and potent antimicrobial compounds is linked to the rise of multidrug resistance. This has sparked international efforts to develop new and improved antimicrobial agents as well as innovative and efficient techniques for antibiotic administration and targeting. There is an evolution in nanotechnology in recent years in treatment and prevention of the biofilm formation and MDR infection. The development of nanomaterial-based therapeutics, which could overcome current pathways linked to acquired drug resistance, is a hopeful strategy for treating difficult-to-treat bacterial infections. Additionally, nanoparticles' distinct size and physical characteristics enable them to target biofilms and treat resistant pathogens. This review highlights the current advances in nanotechnology to combat MDR and biofilm infection. In addition, it provides insight on development and mechanisms of antibiotic resistance, spread of MDR and XDR infection, and development of nanoparticles and mechanisms of their antibacterial activity. Moreover, this review considers the difference between free antibiotics and nanoantibiotics, and the synergistic effect of nanoantibiotics to combat planktonic bacteria, intracellular bacteria and biofilm. Finally, we will discuss the strength and limitations of the application of nanotechnology against bacterial infection and future perspectives.
    Language English
    Publishing date 2023-01-31
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11020413
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Binary CuO\CoO nanoparticles inhibit biofilm formation and reduce the expression of papC and fimH genes in multidrug-resistant Klebsiella oxytoca.

    Aziz, Sarah Naji / Al-Kadmy, Israa M S / Rheima, Ahmed Mahdi / Al-Sallami, Karrar Jasim / Abd Ellah, Noura H / El-Saber Batiha, Gaber / El-Bouseary, Maisra Mohammed / Algammal, Abdelazeem M / Hetta, Helal F

    Molecular biology reports

    2023  Volume 50, Issue 7, Page(s) 5969–5976

    Abstract: Background and aim: Binary copper-cobalt oxide nanoparticles (CuO\CoO NPs) are modern kinds of antimicrobials, which may get a lot of interest in clinical application. This study aimed to detect the effect of the binary CuO\CoO NPs on the expression of ... ...

    Abstract Background and aim: Binary copper-cobalt oxide nanoparticles (CuO\CoO NPs) are modern kinds of antimicrobials, which may get a lot of interest in clinical application. This study aimed to detect the effect of the binary CuO\CoO NPs on the expression of papC and fimH genes in multidrug-resistant (MDR) isolates of Klebsiella oxytoca to reduce medication time and improve outcomes.
    Methods: Ten isolates of K. oxytoca were collected and identified by different conventional tests besides PCR. Antibiotic sensitivity and biofilm-forming ability were carried out. The harboring of papC and fimH genes was also detected. The effect of binary CuO\CoO nanoparticles on the expression of papC and fimH genes was investigated.
    Results: Bacterial resistance against cefotaxime and gentamicin was the highest (100%), while the lowest percentage of resistance was to amikacin (30%). Nine of the ten bacterial isolates had the ability to form a biofilm with different capacities. MIC for binary CuO\CoO NPs was 2.5 µg/mL. Gene expression of papC and fimH was 8.5- and 9-fold lower using the NPs.
    Conclusion: Binary CuO\CoO NPs have a potential therapeutic effect against infections triggered by MDR K. oxytoca strains due to the NPs-related downregulation ability on the virulence genes of K. oxytoca.
    MeSH term(s) Klebsiella oxytoca/genetics ; Anti-Bacterial Agents/pharmacology ; Biofilms ; Nanoparticles ; Microbial Sensitivity Tests
    Chemical Substances cupric oxide (V1XJQ704R4) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-06-03
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 186544-4
    ISSN 1573-4978 ; 0301-4851
    ISSN (online) 1573-4978
    ISSN 0301-4851
    DOI 10.1007/s11033-023-08447-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top